Money Muscle

Money Muscle

Home
Earnings Call
Sectoral Insights
Notebook
Archive
About
SRM Contractors Q1 FY26 Results: PAT up 167%, On-track FY26 Guidance
Guidance of 66% revenue growth in FY26 with stable margins, steady order-inflows and strong revenue visibility. At reasonable valuations based on FY26…
 • 
Money Muscle
SJ Logistics Q1 FY26 Results: PAT up 33%, On-track FY26 Guidance
Guidance of 35-40% FY26 revenue growth. At 5x FY27E PE, attractive valuations for a ₹1,000 Cr business growing at 40% for FY25-27 delivering 12-13% PAT…
 • 
Money Muscle
Genus Power Q1 FY26 Results: PAT up 194%, Can Beat FY26 Guidance
Guiding 60%+ growth with stable margins in FY26 with potential upgrades. Order-book 7x FY26 guidance provides long-term visibility. Attractive forward…
 • 
Money Muscle
Alpex Solar Q1 FY26 Results: PAT up 3890%, Can Beat FY26 Guidance
Guidance of 100% revenue CAGR till FY27. Stable & expanding margins. Order-book supports FY26 guidance. FY27E valuations give leeway to support…
 • 
Money Muscle
Senores Pharmaceuticals Q1 FY26 Results: PAT up 94%, On-track FY26 Guidance
Doubling FY26 PAT with 50% growth in revenue. Potential to deliver 20-30% revenue CAGR in FY27. At reasonable forward valuations with leeway for…
 • 
Money Muscle
India Shelter Finance Q1 FY26 Results: PAT up 44%, Maintain Guidance for FY26
AUM growth of 30-35% in FY26. Issues on asset quality need to be watched. Fully valued on FY26 multiples. Opportunity if growth & asset quality sustain…
 • 
Money Muscle
Australian Premium Solar Q1 FY26 Results: PAT up 125%, Can Beat FY26 Guidance
Guidance of 75% growth with potential upgrades in FY26. Revenue CAGR of 68% for FY25-27. Available at very attractive valuations with leeway for…
 • 
Money Muscle
2
Madhusudan Masala Q1 FY26 Results: PAT up 227%, On-track FY26 Guidance
Strong guidance of 30% CAGR for next 3-5 years. Q1-26 performance ahead of FY26 guidance. Available at very attractive valuations with leeway for…
 • 
Money Muscle

August 2025

Supriya Lifescience Q1 FY26 Results: Promising a Strong H2 After a Weak Q1
Confirms 20% growth guidance for FY26, hitting ₹1,000 Cr revenue by FY27. Maintenance impact in Q1-26 has made execution critical to deliver FY26…
 • 
Money Muscle
Sarda Energy & Minerals Q1 FY26 Results: PAT up 121%; Record Results expected in FY26
Strong case for re-rating as SARDAEN transitions to an energy-led model with visible earnings expansion. Legal uncertainty and high capex intensity…
 • 
Money Muscle
Capacit’e Infraprojects Q1 FY26 Results: Weak Quarter, Confident of Achieving FY26 Guidance
Guidance of 20% CAGR for FY25-28. Despite a weak Q1 a strong order book and attractive valuations create a compelling case for upside as execution…
 • 
Money Muscle
3
Indo Tech Transformers Q1 FY26 Results: PAT up 224%, CAPEX to Constrain Growth
Muted growth till FY27 on account of capacity constraints. Capacity expansion by 70%+ in FY28 could make the valuations look quate attractive as growth…
 • 
Money Muscle
© 2025 Money Muscle
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture